These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17714003)

  • 1. Adverse drug reactions and current state of drug regimen review in nursing facilities: need for a change?
    Bain KT
    Consult Pharm; 2007 Jul; 22(7):586-92. PubMed ID: 17714003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing changes to the state operations manual.
    Martin CM; Saxton-McSpadden C
    Consult Pharm; 2007 Feb; 22(2):105-8, 110-2, 115-7. PubMed ID: 17367245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to clinical practice guidelines for 7 chronic conditions in long-term-care patients who received pharmacist disease management services versus traditional drug regimen review.
    Horning KK; Hoehns JD; Doucette WR
    J Manag Care Pharm; 2007; 13(1):28-36. PubMed ID: 17269834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consultant pharmacists and the survey process.
    McSpadden CS
    Consult Pharm; 2006 Jul; 21(7):556-60. PubMed ID: 16934008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A senior care clerkship for pharmacy students.
    Cooper JW; McCall CY; Marshburn RP; Burfield AH
    Consult Pharm; 2006 Jun; 21(6):482-92. PubMed ID: 16823998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the state operations manual: implications for consultant pharmacy practice.
    Martin CM; McSpadden CS
    Consult Pharm; 2006 Dec; 21(12):948-61. PubMed ID: 17243847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved medication use in long-term care: building on the consultant pharmacist's drug regimen review.
    Harjivan C; Lyles A
    Am J Manag Care; 2002 Apr; 8(4):318-26. PubMed ID: 11950127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and implementation of pharmaceutical care planning software for nursing homes based on the Fleetwood Model.
    Lapane KL; Hiris J; Hughes CM; Feinberg J
    Am J Health Syst Pharm; 2006 Dec; 63(24):2483-7. PubMed ID: 17158696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for medication therapy management services in long-term care facilities.
    Medication Therapy Management Task Force, American Society of Consultant Pharmacists
    Consult Pharm; 2007 Apr; 22(4):355-61. PubMed ID: 17658966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The consultant pharmacist and the physician in the nursing home: roles, relationships, and a recipe for success.
    Levenson SA; Saffel D
    Consult Pharm; 2007 Jan; 22(1):71-82. PubMed ID: 17367254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy interventions undertaken by pharmacists in the Fleetwood phase III study: the role of process control.
    Lapane KL; Hughes CM
    Ann Pharmacother; 2006 Sep; 40(9):1522-6. PubMed ID: 16882872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to the components of the Fleetwood model: self-reported process measures in the Fleetwood Phase III study.
    Lapane KL; Hughes CM
    Consult Pharm; 2006 Dec; 21(12):981-7. PubMed ID: 17243849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing medication-related problems among older Americans.
    Cameron KA
    Manag Care Interface; 1998 Oct; 11(10):74-6, 78, 83-5. PubMed ID: 10186010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of consultant pharmacists in reducing medication problems among older adults receiving Medicaid waiver services.
    Alkema GE; Enguidanos SM; Wilber KH; Trufasiu M; Simmons WJ; Frey D
    Consult Pharm; 2009 Feb; 24(2):121-33. PubMed ID: 19275454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial oversight of medication use: an expanded role for consultant pharmacists.
    Stefanacci RG
    Consult Pharm; 2012 Apr; 27(4):290-5. PubMed ID: 22498989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The health care cost of drug-related morbidity and mortality in nursing facilities.
    Bootman JL; Harrison DL; Cox E
    Arch Intern Med; 1997 Oct; 157(18):2089-96. PubMed ID: 9382665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the need for pharmacist-conducted drug regimen reviews in skilled nursing and intermediate care facilities.
    McGhan WF; Wertheimer AI; Marttila JK
    Contemp Pharm Pract; 1980; 3(4):203-9. PubMed ID: 10298036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What types of nursing facilities are more likely to adopt a pharmacist's medication review recommendations?
    Friesner DL; Scott DM; Dewey MW; Johnson TA; Kessler ML
    Consult Pharm; 2013 Aug; 28(8):490-501. PubMed ID: 23906893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the fleetwood model of long-term care pharmacy.
    Lapane KL; Hughes CM; Christian JB; Daiello LA; Cameron KA; Feinberg J
    J Am Med Dir Assoc; 2011 Jun; 12(5):355-63. PubMed ID: 21450170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving dementia care: new initiatives, new opportunities.
    Martin CM
    Consult Pharm; 2014 Jan; 29(1):16-23. PubMed ID: 24413011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.